Business Segments Neurotech International Limited
Equities
NTI
AU000000NTI9
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0140 AUD | 0.00% |
|
0.00% | - |
| Dec. 16 | Neurotech International receives A$4 million placement commitments | RE |
| Dec. 14 | Neurotech International requests trading halt pending capital raising announcement | RE |
Sales 2025 by Business Segment
Sales 2025 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
| Fiscal Period: June | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Medical Equipment | ||||||||||
Medical Device Development and Distribution | 226K | 608K | 1.19M | 3.18M | 2.44M | |||||
Total Assets | 5.01M | 2.02M | 5.31M | 12.21M | 3.24M | |||||
Interest Expense | -1.71K | -1.37K | - | - | - | |||||
CAPEX | - | -3.2K | - | - | - | |||||
EBT | -7.43M | -3.36M | -7.79M | -5.07M | -10.6M | |||||
D&A | - | - | 1.74K | 583 | 289 | |||||
Operating Income | - | - | - | - | - | |||||
Net Income | -7.43M | -3.36M | -7.79M | -5.07M | -10.6M | |||||
Total Assets | - | - | - | - | - | |||||
Operating Income | - | - | - | - | - | |||||
Operating Income | - | - | - | - | - | |||||
Operating Income | - | - | - | - | - | |||||
Operating Income | - | - | - | - | - |
Geographical Revenue Distribution History
| Fiscal Period: June | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Malta | 226K | 608K | 1.19M | 3.18M | 2.44M | |||||
Total Assets | 5.01M | 2.02M | 5.31M | 12.21M | 3.24M | |||||
Interest Expense | -1.71K | -1.37K | - | - | - | |||||
D&A | - | - | 1.74K | 583 | 289 | |||||
CAPEX | - | -3.2K | - | - | - | |||||
Net Income | -7.43M | -3.36M | -7.79M | -5.07M | -10.6M | |||||
EBT | -7.43M | -3.36M | -7.79M | -5.07M | -10.6M |
- Stock Market
- Equities
- NTI Stock
- Financials Neurotech International Limited
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
